Autoradiographic localization of 3H‐paroxetine‐labeled serotonin uptake sites in rat brain

Synapse - Tập 1 Số 5 - Trang 488-496 - 1987
Errol B. De Souza1, Brian L. Kuyatt1
1Neuroscience Branch, Addiction Research Center, National Institute on Drug Abuse, Alcohol, Drug Abuse, and Mental Health Administration, Baltimore, Maryland 21224

Tóm tắt

AbstractParoxetine is a potent and selective inhibitor of serotonin uptake into neurons. Serotonin uptake sites have been identified, localized, and quantified in rat brain by autoradiography with 3H‐paroxetine; 3H‐paroxetine binding in slide‐mounted sections of rat forebrain was of high affinity (KD = 10 pM) and the inhibition affinity constant (Ki) values of various drugs in competing 3H‐paroxetine binding significantly correlated with their reported potencies in inhibiting synaptosomal serotonin uptake. Serotonin uptake sites labeled by 3H‐paroxetine were highly concentrated in the dorsal and median raphe nuclei, central gray, superficial layer of the superior colliculus, lateral septal nucleus, paraventricular nucleus of the thalamus, and the islands of Calleja. High concentrations of 3H‐paroxetine binding sites were found in brainstem areas containing dopamine (substantia nigra and ventral tegmental area) and norepinephrine (locus coeruleus) cell bodies. Moderate concentrations of 3H‐paroxetine binding sites were present in laminae I and IV of the frontal parietal cortex, primary olfactory cortex, olfactory tubercle, regions of the basal ganglia, septum, amygdala, thalamus, hypothalamus, hippocampus, and some brainstem areas including the interpeduncular, trigeminal, and parabrachial nuclei. Lower densities of 3H‐paroxetine binding sites were found in other regions of the neocortex and very low to nonsignificant levels of binding were present in white matter tracts and in the cerebellum. Lesioning of serotonin neurons with 3,4‐methylenedioxyamphetamine caused large decreases in 3H‐paroxetine binding. The autoradiographic distribution of 3H‐paroxetine binding sites in rat brain corresponds extremely well to the distribution of serotonin terminals and cell bodies as well as with the pharmacological sites of action of serotonin.

Từ khóa


Tài liệu tham khảo

Antonaccio M. J., 1977, Cardiovascular Pharmacology, 131

Aprison M. H., 1975, Serotonergic and cholinergic mechanisms during disruption of approach and avoidance behavior, Fed. Proc., 34, 1813

10.1007/BF00426037

Battaglia G. Yeh S. Y. O'Hearn E. Molliver M. E. Kuhar M. J.andDe Souza E. B.3 4‐Methylenedioxymethamphetamine (MDMA) and 3 4‐Methylenedioxyamphetamine (MDA) preferentially destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of3H‐paroxetine‐labeled serotonin uptake sites.J. Pharmacol. Exp. Ther. in press.

Blundell J. E., 1977, Is there a role for serotonin (5‐hydroxytryptamine) in feeding?, Int. J. Obes., 1, 15

10.1016/0014-2999(78)90243-1

Carter C. J., 1977, Possible importance of 5‐hydroxytryptamine in neuroleptic‐induced catalepsy in rats, Br. J. Pharmacol., 60, 627P

10.1002/cne.901760402

10.1016/0014-2999(74)90019-3

10.1016/0304-3940(86)90397-6

Dahlstrom A., 1964, Evidence for the existence of monoamine containing neurons in the central nervous system—I. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand., 62, 1

D'Amato R. J. Largent B. L. Snowman A. M. andSnyder S. H.Selective labeling of serotonin uptake sites in rat brain by3H‐citalopram contrasted to labeling of multiple sites by3H‐imipramine.J. Pharmacol. Exp. Ther. in press.

10.1016/0361-9230(83)90169-7

10.1111/j.1476-5381.1978.tb07785.x

10.1073/pnas.80.12.3836

Galzin A. M., 1985, Interaction between tricyclic and nontricyclic 5‐hydroxytryptamine uptake inhibitors and the presynaptic 5‐hydroxytryptamine inhibitory autoreceptor in the rat hypothalamus, J. Pharmacol. Exp. Ther., 235, 200

Geller I., 1974, Attenuation of conflict behavior with cinanserin, a serotonin antagonist: Reversal of the effect with 5‐hydroxytryptophan and alpha‐methyltryptamine, Res. Commun. Chem. Pathol. Pharmacol., 7, 165

10.1016/0024-3205(80)90368-9

Gibbons J. L., 1979, Effects of quipazine, fluoxetine, and fenfluramine on muricide in rats, Fed. Proc., 38, 257

10.1016/0014-2999(85)90668-5

10.1016/S0278-5846(82)80178-4

10.1016/0014-2999(85)90135-9

10.1111/j.1749-6632.1977.tb41880.x

10.1016/0006-8993(72)90372-1

Kuhar M. J., 1973, Selective accumulation of 3H‐serotonin by nerve terminals of raphe neurons: An autoradiography study, Nature, 241, 187

10.1111/j.1600-0404.1978.tb04502.x

10.1016/0006-8993(78)90610-8

10.1016/0014-2999(83)90321-7

10.1007/BF02412117

10.1016/0304-3959(77)90083-5

Meyerson B. J., 1978, Biological Determinants of Sexual Behavior, 521

Myers R. D., 1978, Serotonin in Health and Disease, Vol. II. Psychological Regulation and Pharmacological Action, 1

10.1007/BF00498988

O'Hearn E., 1986, Systemic MDA and MDMA, psychotropic substituted amphetamines produce serotonin neurotoxicity, Soc. Neurosci. Abstr., 12, 1233

10.1016/0304-3940(81)90315-3

10.1016/0006-8993(77)90847-2

10.1016/0306-4522(81)90050-6

10.1016/B978-0-12-547620-1.50007-2

10.1016/0014-2999(82)90146-7

10.1016/0006-8993(83)91026-0

10.1212/WNL.36.4.556

10.1126/science.4023719

Saavedra J. M., 1977, Distribution of serotonin and synthesizing enzymes in discrete areas of the brain, Fed. Proc., 36, 2134

10.1016/0024-3205(75)90128-9

10.1111/j.1471-4159.1985.tb04019.x

10.1126/science.7079769

10.1016/0306-4522(81)90146-9

10.1056/NEJM197701132960203

10.1016/0014-2999(79)90110-9

10.1152/physrev.1978.58.4.905

10.1111/j.1600-0773.1975.tb00781.x

10.1016/0091-3057(78)90362-3

Yeh S. Y., 1986, Effects of MDA and MDMA (ecstasy) on brain monoaminergic systems: In vivo studies, Soc. Neurosci. Abstr., 12, 1233

Thông tin
Thông tin xuất bản

Synapse

Tập 1 Số 5

488-496

Thông tin tác giả